Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(CAR T). Showing records 1 – 30 of 31 total matches.

[1] [2]

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


University of Melbourne

1. Davenport, Alexander. Investigating the functional biology of chimeric antigen receptor T cells.

Degree: 2017, University of Melbourne

 Despite the success of autologous chimeric antigen receptor (CAR) T cells to treat patients with refractory B cell acute lymphoblastic leukaemia, (ALL) and lymphoma, there… (more)

Subjects/Keywords: immunology; cancer immunology; immunotherapy; cancer; CAR; chimeric antigen receptor; T cell; CAR T cell

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Davenport, A. (2017). Investigating the functional biology of chimeric antigen receptor T cells. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/137338

Chicago Manual of Style (16th Edition):

Davenport, Alexander. “Investigating the functional biology of chimeric antigen receptor T cells.” 2017. Doctoral Dissertation, University of Melbourne. Accessed December 12, 2019. http://hdl.handle.net/11343/137338.

MLA Handbook (7th Edition):

Davenport, Alexander. “Investigating the functional biology of chimeric antigen receptor T cells.” 2017. Web. 12 Dec 2019.

Vancouver:

Davenport A. Investigating the functional biology of chimeric antigen receptor T cells. [Internet] [Doctoral dissertation]. University of Melbourne; 2017. [cited 2019 Dec 12]. Available from: http://hdl.handle.net/11343/137338.

Council of Science Editors:

Davenport A. Investigating the functional biology of chimeric antigen receptor T cells. [Doctoral Dissertation]. University of Melbourne; 2017. Available from: http://hdl.handle.net/11343/137338


Temple University

2. Purushe, Janaki. MLL4-Menin Complex Inhibition Promotes Central Memory In CD8 CAR-T Cells.

Degree: PhD, 2018, Temple University

Infectious Disease & Immunity

CAR-T cell immunotherapy is a highly efficacious treatment for CD19-positive hematological malignancies, however, some patients are non-responsive for reasons that are… (more)

Subjects/Keywords: Immunology;

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Purushe, J. (2018). MLL4-Menin Complex Inhibition Promotes Central Memory In CD8 CAR-T Cells. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,489872

Chicago Manual of Style (16th Edition):

Purushe, Janaki. “MLL4-Menin Complex Inhibition Promotes Central Memory In CD8 CAR-T Cells.” 2018. Doctoral Dissertation, Temple University. Accessed December 12, 2019. http://digital.library.temple.edu/u?/p245801coll10,489872.

MLA Handbook (7th Edition):

Purushe, Janaki. “MLL4-Menin Complex Inhibition Promotes Central Memory In CD8 CAR-T Cells.” 2018. Web. 12 Dec 2019.

Vancouver:

Purushe J. MLL4-Menin Complex Inhibition Promotes Central Memory In CD8 CAR-T Cells. [Internet] [Doctoral dissertation]. Temple University; 2018. [cited 2019 Dec 12]. Available from: http://digital.library.temple.edu/u?/p245801coll10,489872.

Council of Science Editors:

Purushe J. MLL4-Menin Complex Inhibition Promotes Central Memory In CD8 CAR-T Cells. [Doctoral Dissertation]. Temple University; 2018. Available from: http://digital.library.temple.edu/u?/p245801coll10,489872


University of California – San Diego

3. Chen, Joyce. Defining the Role of Nr4a Transcription Factors in CD8+ T Cell Exhaustion Using a Murine CAR T Cell Tumor Model.

Degree: Biomedical Sciences, 2019, University of California – San Diego

 In cancer immunotherapy, T cells expressing chimeric antigen receptors (CAR T) targeting human CD19 (hCD19) antigen have exhibited impressive clinical efficacy against B cell leukemias… (more)

Subjects/Keywords: Immunology; CAR T cells; Nr4a; T cell exhaustion

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, J. (2019). Defining the Role of Nr4a Transcription Factors in CD8+ T Cell Exhaustion Using a Murine CAR T Cell Tumor Model. (Thesis). University of California – San Diego. Retrieved from http://www.escholarship.org/uc/item/5mj1t7tp

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chen, Joyce. “Defining the Role of Nr4a Transcription Factors in CD8+ T Cell Exhaustion Using a Murine CAR T Cell Tumor Model.” 2019. Thesis, University of California – San Diego. Accessed December 12, 2019. http://www.escholarship.org/uc/item/5mj1t7tp.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chen, Joyce. “Defining the Role of Nr4a Transcription Factors in CD8+ T Cell Exhaustion Using a Murine CAR T Cell Tumor Model.” 2019. Web. 12 Dec 2019.

Vancouver:

Chen J. Defining the Role of Nr4a Transcription Factors in CD8+ T Cell Exhaustion Using a Murine CAR T Cell Tumor Model. [Internet] [Thesis]. University of California – San Diego; 2019. [cited 2019 Dec 12]. Available from: http://www.escholarship.org/uc/item/5mj1t7tp.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chen J. Defining the Role of Nr4a Transcription Factors in CD8+ T Cell Exhaustion Using a Murine CAR T Cell Tumor Model. [Thesis]. University of California – San Diego; 2019. Available from: http://www.escholarship.org/uc/item/5mj1t7tp

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Louisville

4. Murphy, Emily M. Non-viral transfection efficiencies for the advancement of CAR-T therapy.

Degree: M. Eng., 2019, University of Louisville

  Leukemias are the most common form of childhood cancer making up 30% of total pediatric oncological cases, and Acute Lymphoblastic Leukemia (ALL) makes up… (more)

Subjects/Keywords: CAR-T; t-cells; transfection; sonoporation; electroporation; acute lymphoblastic leukemia; Therapeutics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Murphy, E. M. (2019). Non-viral transfection efficiencies for the advancement of CAR-T therapy. (Masters Thesis). University of Louisville. Retrieved from 10.18297/etd/3248 ; https://ir.library.louisville.edu/etd/3248

Chicago Manual of Style (16th Edition):

Murphy, Emily M. “Non-viral transfection efficiencies for the advancement of CAR-T therapy.” 2019. Masters Thesis, University of Louisville. Accessed December 12, 2019. 10.18297/etd/3248 ; https://ir.library.louisville.edu/etd/3248.

MLA Handbook (7th Edition):

Murphy, Emily M. “Non-viral transfection efficiencies for the advancement of CAR-T therapy.” 2019. Web. 12 Dec 2019.

Vancouver:

Murphy EM. Non-viral transfection efficiencies for the advancement of CAR-T therapy. [Internet] [Masters thesis]. University of Louisville; 2019. [cited 2019 Dec 12]. Available from: 10.18297/etd/3248 ; https://ir.library.louisville.edu/etd/3248.

Council of Science Editors:

Murphy EM. Non-viral transfection efficiencies for the advancement of CAR-T therapy. [Masters Thesis]. University of Louisville; 2019. Available from: 10.18297/etd/3248 ; https://ir.library.louisville.edu/etd/3248


McMaster University

5. Hammill, Joanne. PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY.

Degree: PhD, 2018, McMaster University

Advances in our understanding of the molecular events leading to cancer have facilitated the development of next-generation targeted therapies. Among the most promising new approaches… (more)

Subjects/Keywords: Immunology; Immuno-oncology; Chimeric antigen receptor; CAR-T cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hammill, J. (2018). PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY. (Doctoral Dissertation). McMaster University. Retrieved from http://hdl.handle.net/11375/22904

Chicago Manual of Style (16th Edition):

Hammill, Joanne. “PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY.” 2018. Doctoral Dissertation, McMaster University. Accessed December 12, 2019. http://hdl.handle.net/11375/22904.

MLA Handbook (7th Edition):

Hammill, Joanne. “PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY.” 2018. Web. 12 Dec 2019.

Vancouver:

Hammill J. PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY. [Internet] [Doctoral dissertation]. McMaster University; 2018. [cited 2019 Dec 12]. Available from: http://hdl.handle.net/11375/22904.

Council of Science Editors:

Hammill J. PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY. [Doctoral Dissertation]. McMaster University; 2018. Available from: http://hdl.handle.net/11375/22904


Cornell University

6. Park, Spencer. Affinity-tuning leukocyte integrin for development of safe therapeutics .

Degree: 2017, Cornell University

 Much attention has been given to the molecular and cellular pathways linking inflammation with cancer and the local tumor environment to identify new target molecules… (more)

Subjects/Keywords: integrin; Immunology; Biomedical engineering; nanoparticle; Nanotechnology; CAR-T; ICAM-1; cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Park, S. (2017). Affinity-tuning leukocyte integrin for development of safe therapeutics . (Thesis). Cornell University. Retrieved from http://hdl.handle.net/1813/47836

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Park, Spencer. “Affinity-tuning leukocyte integrin for development of safe therapeutics .” 2017. Thesis, Cornell University. Accessed December 12, 2019. http://hdl.handle.net/1813/47836.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Park, Spencer. “Affinity-tuning leukocyte integrin for development of safe therapeutics .” 2017. Web. 12 Dec 2019.

Vancouver:

Park S. Affinity-tuning leukocyte integrin for development of safe therapeutics . [Internet] [Thesis]. Cornell University; 2017. [cited 2019 Dec 12]. Available from: http://hdl.handle.net/1813/47836.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Park S. Affinity-tuning leukocyte integrin for development of safe therapeutics . [Thesis]. Cornell University; 2017. Available from: http://hdl.handle.net/1813/47836

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


UCLA

7. Wattanatorn, Natcha. Nanosphere Lithography for Intracellular Delivery.

Degree: Chemistry, 2019, UCLA

 Nanosphere lithography (NSL) is a simple, high-throughput technique that can be used to form large-area, close-packed monolayer arrays of nanospheres. These arrays can be directly… (more)

Subjects/Keywords: Chemistry; Biomedical engineering; CAR T Cell; gene delivery; nanosphere lithography

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wattanatorn, N. (2019). Nanosphere Lithography for Intracellular Delivery. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/7ct205z6

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Wattanatorn, Natcha. “Nanosphere Lithography for Intracellular Delivery.” 2019. Thesis, UCLA. Accessed December 12, 2019. http://www.escholarship.org/uc/item/7ct205z6.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Wattanatorn, Natcha. “Nanosphere Lithography for Intracellular Delivery.” 2019. Web. 12 Dec 2019.

Vancouver:

Wattanatorn N. Nanosphere Lithography for Intracellular Delivery. [Internet] [Thesis]. UCLA; 2019. [cited 2019 Dec 12]. Available from: http://www.escholarship.org/uc/item/7ct205z6.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Wattanatorn N. Nanosphere Lithography for Intracellular Delivery. [Thesis]. UCLA; 2019. Available from: http://www.escholarship.org/uc/item/7ct205z6

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cambridge

8. Harris, Michael James. Development of an Optogenetic Toolkit for the Interrogation of T cell Signalling Dynamics .

Degree: 2018, University of Cambridge

T cells are a cornerstone of the mammalian adaptive immune system. A range of T-cell subsets exist that can orchestrate the overall immune response to… (more)

Subjects/Keywords: T cell; Optogenetic; LOVTRAP; LOV2; Signalling; Adaptive Immunity; Bispecific Antibodies; FcRH5; Linker for Activation of T cells (LAT); CAR T cell

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Harris, M. J. (2018). Development of an Optogenetic Toolkit for the Interrogation of T cell Signalling Dynamics . (Thesis). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/274251

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Harris, Michael James. “Development of an Optogenetic Toolkit for the Interrogation of T cell Signalling Dynamics .” 2018. Thesis, University of Cambridge. Accessed December 12, 2019. https://www.repository.cam.ac.uk/handle/1810/274251.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Harris, Michael James. “Development of an Optogenetic Toolkit for the Interrogation of T cell Signalling Dynamics .” 2018. Web. 12 Dec 2019.

Vancouver:

Harris MJ. Development of an Optogenetic Toolkit for the Interrogation of T cell Signalling Dynamics . [Internet] [Thesis]. University of Cambridge; 2018. [cited 2019 Dec 12]. Available from: https://www.repository.cam.ac.uk/handle/1810/274251.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Harris MJ. Development of an Optogenetic Toolkit for the Interrogation of T cell Signalling Dynamics . [Thesis]. University of Cambridge; 2018. Available from: https://www.repository.cam.ac.uk/handle/1810/274251

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Washington

9. Grier, Alexandra E. Genome engineering to expand applications of human T-cell immunotherapy.

Degree: PhD, 2017, University of Washington

 Adoptive T-cell therapy, particularly chimeric antigen receptor (CAR) therapy, is a revolutionary and quickly-evolving means of treating cancer patients who can no longer be helped… (more)

Subjects/Keywords: CAR T-cell; checkpoint blockade; genome engineering; immunotherapy; mRNA; Biomedical engineering; Molecular biology; Oncology; Immunology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Grier, A. E. (2017). Genome engineering to expand applications of human T-cell immunotherapy. (Doctoral Dissertation). University of Washington. Retrieved from http://hdl.handle.net/1773/40605

Chicago Manual of Style (16th Edition):

Grier, Alexandra E. “Genome engineering to expand applications of human T-cell immunotherapy.” 2017. Doctoral Dissertation, University of Washington. Accessed December 12, 2019. http://hdl.handle.net/1773/40605.

MLA Handbook (7th Edition):

Grier, Alexandra E. “Genome engineering to expand applications of human T-cell immunotherapy.” 2017. Web. 12 Dec 2019.

Vancouver:

Grier AE. Genome engineering to expand applications of human T-cell immunotherapy. [Internet] [Doctoral dissertation]. University of Washington; 2017. [cited 2019 Dec 12]. Available from: http://hdl.handle.net/1773/40605.

Council of Science Editors:

Grier AE. Genome engineering to expand applications of human T-cell immunotherapy. [Doctoral Dissertation]. University of Washington; 2017. Available from: http://hdl.handle.net/1773/40605


Universidade Estadual de Campinas

10. Franco Jacome, Diego Luis, 1986-. Avalia??o das caracter?sticas f?sico-qu?micas das cinzas de baga?o e palha de cana-de-a??car .

Degree: 2018, Universidade Estadual de Campinas

 Resumo: Neste trabalho foram avaliadas as caracter?sticas f?sicas, qu?micas e mineral?gicas das cinzas de baga?o e palha de cana-de-a??car em fun??o da temperatura de combust?o,… (more)

Subjects/Keywords: Biomassa - Combust?o; Cana-de-a??car; Caracteriza??o; An?lise t?rmica

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Franco Jacome, Diego Luis, 1. (2018). Avalia??o das caracter?sticas f?sico-qu?micas das cinzas de baga?o e palha de cana-de-a??car . (Thesis). Universidade Estadual de Campinas. Retrieved from http://repositorio.unicamp.br/jspui/handle/REPOSIP/333659

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Franco Jacome, Diego Luis, 1986-. “Avalia??o das caracter?sticas f?sico-qu?micas das cinzas de baga?o e palha de cana-de-a??car .” 2018. Thesis, Universidade Estadual de Campinas. Accessed December 12, 2019. http://repositorio.unicamp.br/jspui/handle/REPOSIP/333659.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Franco Jacome, Diego Luis, 1986-. “Avalia??o das caracter?sticas f?sico-qu?micas das cinzas de baga?o e palha de cana-de-a??car .” 2018. Web. 12 Dec 2019.

Vancouver:

Franco Jacome, Diego Luis 1. Avalia??o das caracter?sticas f?sico-qu?micas das cinzas de baga?o e palha de cana-de-a??car . [Internet] [Thesis]. Universidade Estadual de Campinas; 2018. [cited 2019 Dec 12]. Available from: http://repositorio.unicamp.br/jspui/handle/REPOSIP/333659.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Franco Jacome, Diego Luis 1. Avalia??o das caracter?sticas f?sico-qu?micas das cinzas de baga?o e palha de cana-de-a??car . [Thesis]. Universidade Estadual de Campinas; 2018. Available from: http://repositorio.unicamp.br/jspui/handle/REPOSIP/333659

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Houston

11. Liadi, Ivan. High-Throughput Single-Cell Functional and Molecular Profiling of Immune Cells in Cancer Immunotherapy.

Degree: Chemical and Biomolecular Engineering, Department of, 2015, University of Houston

 Immunotherapy has revolutionized the treatment of cancer and newer approaches including the adoptive transfer of genetically modified T cells reprogrammed to target tumor antigens have… (more)

Subjects/Keywords: Single-cell; TIMING; high-throughput; CAR T cells; cytokine; single-cell gene expression; beads

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Liadi, I. (2015). High-Throughput Single-Cell Functional and Molecular Profiling of Immune Cells in Cancer Immunotherapy. (Thesis). University of Houston. Retrieved from http://hdl.handle.net/10657/1929

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Liadi, Ivan. “High-Throughput Single-Cell Functional and Molecular Profiling of Immune Cells in Cancer Immunotherapy.” 2015. Thesis, University of Houston. Accessed December 12, 2019. http://hdl.handle.net/10657/1929.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Liadi, Ivan. “High-Throughput Single-Cell Functional and Molecular Profiling of Immune Cells in Cancer Immunotherapy.” 2015. Web. 12 Dec 2019.

Vancouver:

Liadi I. High-Throughput Single-Cell Functional and Molecular Profiling of Immune Cells in Cancer Immunotherapy. [Internet] [Thesis]. University of Houston; 2015. [cited 2019 Dec 12]. Available from: http://hdl.handle.net/10657/1929.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Liadi I. High-Throughput Single-Cell Functional and Molecular Profiling of Immune Cells in Cancer Immunotherapy. [Thesis]. University of Houston; 2015. Available from: http://hdl.handle.net/10657/1929

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of California – San Diego

12. Zamat, Ali H. Generation of a Genetic Circuit for the Spatial and Temporal Control of Cell Function.

Degree: Bioengineering, 2019, University of California – San Diego

 With recent advancements in gene engineering, cellular functions have been utilized in therapeutics and diagnostics in an unprecedent amount. However, biological mechanisms for many cell… (more)

Subjects/Keywords: Bioengineering; CAR-T Therapy; Gene Activation; Gene Circuit; Gene Engineering; Ultrasound Activation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zamat, A. H. (2019). Generation of a Genetic Circuit for the Spatial and Temporal Control of Cell Function. (Thesis). University of California – San Diego. Retrieved from http://www.escholarship.org/uc/item/4g22f0dz

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zamat, Ali H. “Generation of a Genetic Circuit for the Spatial and Temporal Control of Cell Function.” 2019. Thesis, University of California – San Diego. Accessed December 12, 2019. http://www.escholarship.org/uc/item/4g22f0dz.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zamat, Ali H. “Generation of a Genetic Circuit for the Spatial and Temporal Control of Cell Function.” 2019. Web. 12 Dec 2019.

Vancouver:

Zamat AH. Generation of a Genetic Circuit for the Spatial and Temporal Control of Cell Function. [Internet] [Thesis]. University of California – San Diego; 2019. [cited 2019 Dec 12]. Available from: http://www.escholarship.org/uc/item/4g22f0dz.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zamat AH. Generation of a Genetic Circuit for the Spatial and Temporal Control of Cell Function. [Thesis]. University of California – San Diego; 2019. Available from: http://www.escholarship.org/uc/item/4g22f0dz

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

13. Patel, Krina K. EMPLOYING T CELLS FOR ANTIGEN PRESENTATION: ROLE OF NY-ESO-1+ T-APC VACCINE IN MULTIPLE MYELOMA.

Degree: MS, 2016, Texas Medical Center

  Introduction: Cellular therapy has shown great potential in early phase clinical trials with persistence of effector cells appearing to lead to improved outcomes. Combined… (more)

Subjects/Keywords: cellular therapy; multiple myeloma; CAR T cells; cancer vaccines; NY-ESO-1; T-APC; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Patel, K. K. (2016). EMPLOYING T CELLS FOR ANTIGEN PRESENTATION: ROLE OF NY-ESO-1+ T-APC VACCINE IN MULTIPLE MYELOMA. (Masters Thesis). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/707

Chicago Manual of Style (16th Edition):

Patel, Krina K. “EMPLOYING T CELLS FOR ANTIGEN PRESENTATION: ROLE OF NY-ESO-1+ T-APC VACCINE IN MULTIPLE MYELOMA.” 2016. Masters Thesis, Texas Medical Center. Accessed December 12, 2019. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/707.

MLA Handbook (7th Edition):

Patel, Krina K. “EMPLOYING T CELLS FOR ANTIGEN PRESENTATION: ROLE OF NY-ESO-1+ T-APC VACCINE IN MULTIPLE MYELOMA.” 2016. Web. 12 Dec 2019.

Vancouver:

Patel KK. EMPLOYING T CELLS FOR ANTIGEN PRESENTATION: ROLE OF NY-ESO-1+ T-APC VACCINE IN MULTIPLE MYELOMA. [Internet] [Masters thesis]. Texas Medical Center; 2016. [cited 2019 Dec 12]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/707.

Council of Science Editors:

Patel KK. EMPLOYING T CELLS FOR ANTIGEN PRESENTATION: ROLE OF NY-ESO-1+ T-APC VACCINE IN MULTIPLE MYELOMA. [Masters Thesis]. Texas Medical Center; 2016. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/707

14. PNG YI TIAN. DEVELOPMENT OF NOVEL T-CELL BASED THERAPIES FOR LYMPHOID MALIGNANCIES.

Degree: 2018, National University of Singapore

Subjects/Keywords: CAR; T cell; leukaemia; PEBL; CD7; T-ALL

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

TIAN, P. Y. (2018). DEVELOPMENT OF NOVEL T-CELL BASED THERAPIES FOR LYMPHOID MALIGNANCIES. (Thesis). National University of Singapore. Retrieved from http://scholarbank.nus.edu.sg/handle/10635/147495

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

TIAN, PNG YI. “DEVELOPMENT OF NOVEL T-CELL BASED THERAPIES FOR LYMPHOID MALIGNANCIES.” 2018. Thesis, National University of Singapore. Accessed December 12, 2019. http://scholarbank.nus.edu.sg/handle/10635/147495.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

TIAN, PNG YI. “DEVELOPMENT OF NOVEL T-CELL BASED THERAPIES FOR LYMPHOID MALIGNANCIES.” 2018. Web. 12 Dec 2019.

Vancouver:

TIAN PY. DEVELOPMENT OF NOVEL T-CELL BASED THERAPIES FOR LYMPHOID MALIGNANCIES. [Internet] [Thesis]. National University of Singapore; 2018. [cited 2019 Dec 12]. Available from: http://scholarbank.nus.edu.sg/handle/10635/147495.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

TIAN PY. DEVELOPMENT OF NOVEL T-CELL BASED THERAPIES FOR LYMPHOID MALIGNANCIES. [Thesis]. National University of Singapore; 2018. Available from: http://scholarbank.nus.edu.sg/handle/10635/147495

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


UCLA

15. Lorenzini, Michael Hideo. Engineering Robust T-Cell Response Against Immunosuppressive Tumors.

Degree: Bioengineering, 2016, UCLA

 With the establishment of clinically effective adoptive T-cell therapy for metastatic cancer, efforts are growing to advance T-cell therapy for new indications, especially solid tumors.… (more)

Subjects/Keywords: Immunology; Biomedical engineering; Molecular biology; Adoptive cell therapy; Cancer immunosuppression; Cancer immunotherapy; CAR-T cells; Chimeric antigen receptor; TGF beta

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lorenzini, M. H. (2016). Engineering Robust T-Cell Response Against Immunosuppressive Tumors. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/26h6c920

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lorenzini, Michael Hideo. “Engineering Robust T-Cell Response Against Immunosuppressive Tumors.” 2016. Thesis, UCLA. Accessed December 12, 2019. http://www.escholarship.org/uc/item/26h6c920.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lorenzini, Michael Hideo. “Engineering Robust T-Cell Response Against Immunosuppressive Tumors.” 2016. Web. 12 Dec 2019.

Vancouver:

Lorenzini MH. Engineering Robust T-Cell Response Against Immunosuppressive Tumors. [Internet] [Thesis]. UCLA; 2016. [cited 2019 Dec 12]. Available from: http://www.escholarship.org/uc/item/26h6c920.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lorenzini MH. Engineering Robust T-Cell Response Against Immunosuppressive Tumors. [Thesis]. UCLA; 2016. Available from: http://www.escholarship.org/uc/item/26h6c920

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of California – San Diego

16. Allen, Molly Elizabeth. Using Light to Improve CAR T Cell Immunotherapy Development and Applications.

Degree: Bioengineering, 2019, University of California – San Diego

 Cancer is the second-leading cause of death worldwide. Over the past two decades, chimeric antigen receptor (CAR) T cell therapy has emerged as a promising… (more)

Subjects/Keywords: Bioengineering; Molecular biology; Biomedical engineering; Biosensor; Chimeric Antigen Receptor (CAR); Immunotherapy; Optogenetics; Synthetic Biology; T cell

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Allen, M. E. (2019). Using Light to Improve CAR T Cell Immunotherapy Development and Applications. (Thesis). University of California – San Diego. Retrieved from http://www.escholarship.org/uc/item/8bk4w5hc

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Allen, Molly Elizabeth. “Using Light to Improve CAR T Cell Immunotherapy Development and Applications.” 2019. Thesis, University of California – San Diego. Accessed December 12, 2019. http://www.escholarship.org/uc/item/8bk4w5hc.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Allen, Molly Elizabeth. “Using Light to Improve CAR T Cell Immunotherapy Development and Applications.” 2019. Web. 12 Dec 2019.

Vancouver:

Allen ME. Using Light to Improve CAR T Cell Immunotherapy Development and Applications. [Internet] [Thesis]. University of California – San Diego; 2019. [cited 2019 Dec 12]. Available from: http://www.escholarship.org/uc/item/8bk4w5hc.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Allen ME. Using Light to Improve CAR T Cell Immunotherapy Development and Applications. [Thesis]. University of California – San Diego; 2019. Available from: http://www.escholarship.org/uc/item/8bk4w5hc

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of California – San Diego

17. Limsakul, Praopim. Engineering Molecular Modules Through Directed Evolution for Applications in Single-Cell Imaging and Immunotherapy.

Degree: Bioengineering, 2019, University of California – San Diego

 Protein engineering through directed evolution has been extensively used to improve and modify the structure and function of proteins for wide range of applications. In… (more)

Subjects/Keywords: Bioengineering; CAR T cell therapy; Directed evolution; FACS-based FRET; FRET biosensors; High-throughput screening; MT1-MMP

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Limsakul, P. (2019). Engineering Molecular Modules Through Directed Evolution for Applications in Single-Cell Imaging and Immunotherapy. (Thesis). University of California – San Diego. Retrieved from http://www.escholarship.org/uc/item/7x01b05n

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Limsakul, Praopim. “Engineering Molecular Modules Through Directed Evolution for Applications in Single-Cell Imaging and Immunotherapy.” 2019. Thesis, University of California – San Diego. Accessed December 12, 2019. http://www.escholarship.org/uc/item/7x01b05n.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Limsakul, Praopim. “Engineering Molecular Modules Through Directed Evolution for Applications in Single-Cell Imaging and Immunotherapy.” 2019. Web. 12 Dec 2019.

Vancouver:

Limsakul P. Engineering Molecular Modules Through Directed Evolution for Applications in Single-Cell Imaging and Immunotherapy. [Internet] [Thesis]. University of California – San Diego; 2019. [cited 2019 Dec 12]. Available from: http://www.escholarship.org/uc/item/7x01b05n.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Limsakul P. Engineering Molecular Modules Through Directed Evolution for Applications in Single-Cell Imaging and Immunotherapy. [Thesis]. University of California – San Diego; 2019. Available from: http://www.escholarship.org/uc/item/7x01b05n

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

18. Drent, Esther. Towards safe and effective CD38-CAR T cell therapy for myeloma.

Degree: 2018, University Utrecht

 Immunotherapy is a promising field within cancer therapy. The recent progresses resulted in 'Immunotherapy for the treatment of cancer' as break-through of the year in… (more)

Subjects/Keywords: Immunotherapy; CAR T cells; CD38; Multiple myeloma; hematology; immunology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Drent, E. (2018). Towards safe and effective CD38-CAR T cell therapy for myeloma. (Doctoral Dissertation). University Utrecht. Retrieved from http://dspace.library.uu.nl/handle/1874/363447 ; URN:NBN:NL:UI:10-1874-363447 ; urn:isbn:978-94-6182-868-2 ; URN:NBN:NL:UI:10-1874-363447 ; http://dspace.library.uu.nl/handle/1874/363447

Chicago Manual of Style (16th Edition):

Drent, Esther. “Towards safe and effective CD38-CAR T cell therapy for myeloma.” 2018. Doctoral Dissertation, University Utrecht. Accessed December 12, 2019. http://dspace.library.uu.nl/handle/1874/363447 ; URN:NBN:NL:UI:10-1874-363447 ; urn:isbn:978-94-6182-868-2 ; URN:NBN:NL:UI:10-1874-363447 ; http://dspace.library.uu.nl/handle/1874/363447.

MLA Handbook (7th Edition):

Drent, Esther. “Towards safe and effective CD38-CAR T cell therapy for myeloma.” 2018. Web. 12 Dec 2019.

Vancouver:

Drent E. Towards safe and effective CD38-CAR T cell therapy for myeloma. [Internet] [Doctoral dissertation]. University Utrecht; 2018. [cited 2019 Dec 12]. Available from: http://dspace.library.uu.nl/handle/1874/363447 ; URN:NBN:NL:UI:10-1874-363447 ; urn:isbn:978-94-6182-868-2 ; URN:NBN:NL:UI:10-1874-363447 ; http://dspace.library.uu.nl/handle/1874/363447.

Council of Science Editors:

Drent E. Towards safe and effective CD38-CAR T cell therapy for myeloma. [Doctoral Dissertation]. University Utrecht; 2018. Available from: http://dspace.library.uu.nl/handle/1874/363447 ; URN:NBN:NL:UI:10-1874-363447 ; urn:isbn:978-94-6182-868-2 ; URN:NBN:NL:UI:10-1874-363447 ; http://dspace.library.uu.nl/handle/1874/363447


University of Pennsylvania

19. Lynn, Rachel Christina. Frβ-Directed Car T Cells for Immunotherapy of Cancer.

Degree: 2015, University of Pennsylvania

T-cells expressing chimeric antigen receptors (CARs) can elicit dramatic clinical responses in CD19+ malignancies; however, therapeutic options for acute myeloid leukemia (AML) and solid tumors… (more)

Subjects/Keywords: AML; Cancer Immunotherapy; CAR T cells; FRβ; Allergy and Immunology; Cell Biology; Immunology and Infectious Disease; Medical Immunology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lynn, R. C. (2015). Frβ-Directed Car T Cells for Immunotherapy of Cancer. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/1866

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lynn, Rachel Christina. “Frβ-Directed Car T Cells for Immunotherapy of Cancer.” 2015. Thesis, University of Pennsylvania. Accessed December 12, 2019. https://repository.upenn.edu/edissertations/1866.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lynn, Rachel Christina. “Frβ-Directed Car T Cells for Immunotherapy of Cancer.” 2015. Web. 12 Dec 2019.

Vancouver:

Lynn RC. Frβ-Directed Car T Cells for Immunotherapy of Cancer. [Internet] [Thesis]. University of Pennsylvania; 2015. [cited 2019 Dec 12]. Available from: https://repository.upenn.edu/edissertations/1866.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lynn RC. Frβ-Directed Car T Cells for Immunotherapy of Cancer. [Thesis]. University of Pennsylvania; 2015. Available from: https://repository.upenn.edu/edissertations/1866

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pennsylvania

20. Lo, Albert. Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma.

Degree: 2016, University of Pennsylvania

 Primary carcinomas and metastases are complex organ-like structures composed of malignant parenchymal epithelial tissues and a desmoplastic stroma formed by accumulation of hematopoietic cells, mesenchymal… (more)

Subjects/Keywords: Cancer-associated fibroblasts (CAFs); Chimeric antigen receptor (CAR) T cells; Fibroblast activation protein (FAP); Tumor microenvironment; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lo, A. (2016). Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/1862

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lo, Albert. “Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma.” 2016. Thesis, University of Pennsylvania. Accessed December 12, 2019. https://repository.upenn.edu/edissertations/1862.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lo, Albert. “Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma.” 2016. Web. 12 Dec 2019.

Vancouver:

Lo A. Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma. [Internet] [Thesis]. University of Pennsylvania; 2016. [cited 2019 Dec 12]. Available from: https://repository.upenn.edu/edissertations/1862.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lo A. Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma. [Thesis]. University of Pennsylvania; 2016. Available from: https://repository.upenn.edu/edissertations/1862

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

21. Drent, Esther. Towards safe and effective CD38-CAR T cell therapy for myeloma.

Degree: 2018, University Utrecht

 Immunotherapy is a promising field within cancer therapy. The recent progresses resulted in 'Immunotherapy for the treatment of cancer' as break-through of the year in… (more)

Subjects/Keywords: Immunotherapy; CAR T cells; CD38; Multiple myeloma; hematology; immunology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Drent, E. (2018). Towards safe and effective CD38-CAR T cell therapy for myeloma. (Doctoral Dissertation). University Utrecht. Retrieved from http://dspace.library.uu.nl/handle/1874/363447 ; URN:NBN:NL:UI:10-1874-363447 ; urn:isbn:978-94-6182-868-2 ; URN:NBN:NL:UI:10-1874-363447 ; http://dspace.library.uu.nl/handle/1874/363447

Chicago Manual of Style (16th Edition):

Drent, Esther. “Towards safe and effective CD38-CAR T cell therapy for myeloma.” 2018. Doctoral Dissertation, University Utrecht. Accessed December 12, 2019. http://dspace.library.uu.nl/handle/1874/363447 ; URN:NBN:NL:UI:10-1874-363447 ; urn:isbn:978-94-6182-868-2 ; URN:NBN:NL:UI:10-1874-363447 ; http://dspace.library.uu.nl/handle/1874/363447.

MLA Handbook (7th Edition):

Drent, Esther. “Towards safe and effective CD38-CAR T cell therapy for myeloma.” 2018. Web. 12 Dec 2019.

Vancouver:

Drent E. Towards safe and effective CD38-CAR T cell therapy for myeloma. [Internet] [Doctoral dissertation]. University Utrecht; 2018. [cited 2019 Dec 12]. Available from: http://dspace.library.uu.nl/handle/1874/363447 ; URN:NBN:NL:UI:10-1874-363447 ; urn:isbn:978-94-6182-868-2 ; URN:NBN:NL:UI:10-1874-363447 ; http://dspace.library.uu.nl/handle/1874/363447.

Council of Science Editors:

Drent E. Towards safe and effective CD38-CAR T cell therapy for myeloma. [Doctoral Dissertation]. University Utrecht; 2018. Available from: http://dspace.library.uu.nl/handle/1874/363447 ; URN:NBN:NL:UI:10-1874-363447 ; urn:isbn:978-94-6182-868-2 ; URN:NBN:NL:UI:10-1874-363447 ; http://dspace.library.uu.nl/handle/1874/363447

22. Asgarov, Kamal. Development of more precise and efficient antibodies for cancer targeting : membrane associated form specific anti-mesothelin antibodies and CAR as an example : Développement d'anticorps plus précis et efficaces pour le ciblage du cancer : anticorps et CAR anti-mésothéline spécifiques de la membrane comme exemple.

Degree: Docteur es, Sciences de la vie et de la santé, 2016, Besançon

Utilistions d'anticorps monoclonaux est une partie prometteuse de la thérapie du cancer. À ce jour, il existe plus de 30 anticorps monoclonaux approuvés pour la… (more)

Subjects/Keywords: Mésothéline; Affichage de phages; Tolérance immunitaire; Immunisation; Cellules T de CAR; Anticorps monoclonaux; Séquence VH-CDR3; 1H7; Mesothelin; Phage display; Tolerized immunization; Immunisation; CAR T cells; Monoclonal antibodies; VH-CDR3 Sequence; 1H7; 616.9; QW 575.5.A6

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Asgarov, K. (2016). Development of more precise and efficient antibodies for cancer targeting : membrane associated form specific anti-mesothelin antibodies and CAR as an example : Développement d'anticorps plus précis et efficaces pour le ciblage du cancer : anticorps et CAR anti-mésothéline spécifiques de la membrane comme exemple. (Doctoral Dissertation). Besançon. Retrieved from http://www.theses.fr/2016BESA3013

Chicago Manual of Style (16th Edition):

Asgarov, Kamal. “Development of more precise and efficient antibodies for cancer targeting : membrane associated form specific anti-mesothelin antibodies and CAR as an example : Développement d'anticorps plus précis et efficaces pour le ciblage du cancer : anticorps et CAR anti-mésothéline spécifiques de la membrane comme exemple.” 2016. Doctoral Dissertation, Besançon. Accessed December 12, 2019. http://www.theses.fr/2016BESA3013.

MLA Handbook (7th Edition):

Asgarov, Kamal. “Development of more precise and efficient antibodies for cancer targeting : membrane associated form specific anti-mesothelin antibodies and CAR as an example : Développement d'anticorps plus précis et efficaces pour le ciblage du cancer : anticorps et CAR anti-mésothéline spécifiques de la membrane comme exemple.” 2016. Web. 12 Dec 2019.

Vancouver:

Asgarov K. Development of more precise and efficient antibodies for cancer targeting : membrane associated form specific anti-mesothelin antibodies and CAR as an example : Développement d'anticorps plus précis et efficaces pour le ciblage du cancer : anticorps et CAR anti-mésothéline spécifiques de la membrane comme exemple. [Internet] [Doctoral dissertation]. Besançon; 2016. [cited 2019 Dec 12]. Available from: http://www.theses.fr/2016BESA3013.

Council of Science Editors:

Asgarov K. Development of more precise and efficient antibodies for cancer targeting : membrane associated form specific anti-mesothelin antibodies and CAR as an example : Développement d'anticorps plus précis et efficaces pour le ciblage du cancer : anticorps et CAR anti-mésothéline spécifiques de la membrane comme exemple. [Doctoral Dissertation]. Besançon; 2016. Available from: http://www.theses.fr/2016BESA3013

23. DU SHOUHUI. CO-EXPANSION OF GAMMA DELTA T CELLS AND CYTOKINE INDUCED KILLER CELLS FOR ADOPTIVE IMMUNE CELL THERAPY.

Degree: 2015, National University of Singapore

Subjects/Keywords: gamma delta T; CIK; CAR-T; adoptive T cell therapy; co-expansion; feeder layer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

SHOUHUI, D. (2015). CO-EXPANSION OF GAMMA DELTA T CELLS AND CYTOKINE INDUCED KILLER CELLS FOR ADOPTIVE IMMUNE CELL THERAPY. (Thesis). National University of Singapore. Retrieved from http://scholarbank.nus.edu.sg/handle/10635/122772

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

SHOUHUI, DU. “CO-EXPANSION OF GAMMA DELTA T CELLS AND CYTOKINE INDUCED KILLER CELLS FOR ADOPTIVE IMMUNE CELL THERAPY.” 2015. Thesis, National University of Singapore. Accessed December 12, 2019. http://scholarbank.nus.edu.sg/handle/10635/122772.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

SHOUHUI, DU. “CO-EXPANSION OF GAMMA DELTA T CELLS AND CYTOKINE INDUCED KILLER CELLS FOR ADOPTIVE IMMUNE CELL THERAPY.” 2015. Web. 12 Dec 2019.

Vancouver:

SHOUHUI D. CO-EXPANSION OF GAMMA DELTA T CELLS AND CYTOKINE INDUCED KILLER CELLS FOR ADOPTIVE IMMUNE CELL THERAPY. [Internet] [Thesis]. National University of Singapore; 2015. [cited 2019 Dec 12]. Available from: http://scholarbank.nus.edu.sg/handle/10635/122772.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

SHOUHUI D. CO-EXPANSION OF GAMMA DELTA T CELLS AND CYTOKINE INDUCED KILLER CELLS FOR ADOPTIVE IMMUNE CELL THERAPY. [Thesis]. National University of Singapore; 2015. Available from: http://scholarbank.nus.edu.sg/handle/10635/122772

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

24. Crossland, Denise L. CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN.

Degree: PhD, 2014, Texas Medical Center

  The CD56 antigen is expressed on several deadly malignancies currently lacking long-term efficacious therapies. Chimeric antigen receptor (CAR) based immunotherapies have shown both safety… (more)

Subjects/Keywords: Chimeric Antigen Receptor; CAR; Neural Cell Adhesion Molecule; NCAM; CD56; Fratricide; Autolysis; T cell immunotherapy; self-targeting; CD56CAR; Cancer Biology; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Crossland, D. L. (2014). CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/493

Chicago Manual of Style (16th Edition):

Crossland, Denise L. “CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN.” 2014. Doctoral Dissertation, Texas Medical Center. Accessed December 12, 2019. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/493.

MLA Handbook (7th Edition):

Crossland, Denise L. “CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN.” 2014. Web. 12 Dec 2019.

Vancouver:

Crossland DL. CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN. [Internet] [Doctoral dissertation]. Texas Medical Center; 2014. [cited 2019 Dec 12]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/493.

Council of Science Editors:

Crossland DL. CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN. [Doctoral Dissertation]. Texas Medical Center; 2014. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/493

25. Reddy, Naveen Kumar Munagala. Changing landscape of immuno-oncology: CAR-T therapy and PD1/PDL1 blockade.

Degree: MS, Medical Sciences, 2016, Boston University

 The current field of cancer treatment is undergoing a revolution. The influx of novel therapies derived from basic research on the immune system has shifted… (more)

Subjects/Keywords: Medicine; Cancer; CAR-T; CTLA4; Immunotherapeutics; PD1; Cancer review

…LIST OF TABLES Table Title Page 1 CAR-T Clinical Trials 13 2 Summary of Clinical… …chimeric antigen receptor 5 2 Mechanism of T cell Activation 7 3 Evolution of CAR-T cell… …mechanism of action, efficacy, and future of two promising trends in immunotherapy: CAR-T cells… …and checkpoint blockade History Of CAR-T Therapy CAR-T cells are T cells that have been… …engineered to detect and eradicate tumor cells. The history of CAR-T cells can be first traced back… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Reddy, N. K. M. (2016). Changing landscape of immuno-oncology: CAR-T therapy and PD1/PDL1 blockade. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/17000

Chicago Manual of Style (16th Edition):

Reddy, Naveen Kumar Munagala. “Changing landscape of immuno-oncology: CAR-T therapy and PD1/PDL1 blockade.” 2016. Masters Thesis, Boston University. Accessed December 12, 2019. http://hdl.handle.net/2144/17000.

MLA Handbook (7th Edition):

Reddy, Naveen Kumar Munagala. “Changing landscape of immuno-oncology: CAR-T therapy and PD1/PDL1 blockade.” 2016. Web. 12 Dec 2019.

Vancouver:

Reddy NKM. Changing landscape of immuno-oncology: CAR-T therapy and PD1/PDL1 blockade. [Internet] [Masters thesis]. Boston University; 2016. [cited 2019 Dec 12]. Available from: http://hdl.handle.net/2144/17000.

Council of Science Editors:

Reddy NKM. Changing landscape of immuno-oncology: CAR-T therapy and PD1/PDL1 blockade. [Masters Thesis]. Boston University; 2016. Available from: http://hdl.handle.net/2144/17000

26. Krieg, Richard. Celgene & Juno Therapeutics : M&A in the biopharmaceutical industry.

Degree: 2018, RCAAP

On the 22nd January 2018, the US American biopharmaceutical company Celgene Corporation announced the signing of a definitive merger agreement with their research partner Juno… (more)

Subjects/Keywords: Mergers; Acquisitions; CAR-T; Cancer; USA; Biopharmaceuticals; Pharmaceuticals; Biotechnology; Research; Development; Fusões; Aquisições; Estados Unidos; Câncer; Biofarmacêuticos; Farmacêuticos; Biotecnologia; Pesquisa; Desenvolvimento; Domínio/Área Científica::Ciências Sociais::Economia e Gestão

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Krieg, R. (2018). Celgene & Juno Therapeutics : M&A in the biopharmaceutical industry. (Thesis). RCAAP. Retrieved from https://www.rcaap.pt/detail.jsp?id=oai:repositorio.ucp.pt:10400.14/25469

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Krieg, Richard. “Celgene & Juno Therapeutics : M&A in the biopharmaceutical industry.” 2018. Thesis, RCAAP. Accessed December 12, 2019. https://www.rcaap.pt/detail.jsp?id=oai:repositorio.ucp.pt:10400.14/25469.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Krieg, Richard. “Celgene & Juno Therapeutics : M&A in the biopharmaceutical industry.” 2018. Web. 12 Dec 2019.

Vancouver:

Krieg R. Celgene & Juno Therapeutics : M&A in the biopharmaceutical industry. [Internet] [Thesis]. RCAAP; 2018. [cited 2019 Dec 12]. Available from: https://www.rcaap.pt/detail.jsp?id=oai:repositorio.ucp.pt:10400.14/25469.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Krieg R. Celgene & Juno Therapeutics : M&A in the biopharmaceutical industry. [Thesis]. RCAAP; 2018. Available from: https://www.rcaap.pt/detail.jsp?id=oai:repositorio.ucp.pt:10400.14/25469

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pennsylvania

27. Smith, Jenessa Barbara. Treating Cancer With Engineered T Cell Therapies: Murine and Canine Models of Safety and Efficacy.

Degree: 2016, University of Pennsylvania

 Redirecting a patient’s T-cells against cancer shows tremendous clinical responses in certain tumor types, but potent therapies for ovarian cancer remain limited. Here we describe… (more)

Subjects/Keywords: Canine Immune Therapy; CAR; Immune Therapy; Ovarian Cancer; T cell; TCR; Allergy and Immunology; Cell Biology; Immunology and Infectious Disease; Medical Immunology; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Smith, J. B. (2016). Treating Cancer With Engineered T Cell Therapies: Murine and Canine Models of Safety and Efficacy. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/2026

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Smith, Jenessa Barbara. “Treating Cancer With Engineered T Cell Therapies: Murine and Canine Models of Safety and Efficacy.” 2016. Thesis, University of Pennsylvania. Accessed December 12, 2019. https://repository.upenn.edu/edissertations/2026.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Smith, Jenessa Barbara. “Treating Cancer With Engineered T Cell Therapies: Murine and Canine Models of Safety and Efficacy.” 2016. Web. 12 Dec 2019.

Vancouver:

Smith JB. Treating Cancer With Engineered T Cell Therapies: Murine and Canine Models of Safety and Efficacy. [Internet] [Thesis]. University of Pennsylvania; 2016. [cited 2019 Dec 12]. Available from: https://repository.upenn.edu/edissertations/2026.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Smith JB. Treating Cancer With Engineered T Cell Therapies: Murine and Canine Models of Safety and Efficacy. [Thesis]. University of Pennsylvania; 2016. Available from: https://repository.upenn.edu/edissertations/2026

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pennsylvania

28. Yarmarkovich, Mark. Immunotherapeutic Targeting Of Lineage Restricted Oncoproteins In Immunogenically Silent Tumors.

Degree: 2019, University of Pennsylvania

 Recent breakthroughs in biotechnology and immunology have allowed the immune system to be harnessed in the cure of some cancers. Thus far clinical successes using… (more)

Subjects/Keywords: Adoptive cell therapy; CAR T cell therapy; Immunoediting; Neuroblastoma; TCR engineering; Allergy and Immunology; Immunology and Infectious Disease; Medical Immunology; Molecular Biology; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yarmarkovich, M. (2019). Immunotherapeutic Targeting Of Lineage Restricted Oncoproteins In Immunogenically Silent Tumors. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/3529

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Yarmarkovich, Mark. “Immunotherapeutic Targeting Of Lineage Restricted Oncoproteins In Immunogenically Silent Tumors.” 2019. Thesis, University of Pennsylvania. Accessed December 12, 2019. https://repository.upenn.edu/edissertations/3529.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Yarmarkovich, Mark. “Immunotherapeutic Targeting Of Lineage Restricted Oncoproteins In Immunogenically Silent Tumors.” 2019. Web. 12 Dec 2019.

Vancouver:

Yarmarkovich M. Immunotherapeutic Targeting Of Lineage Restricted Oncoproteins In Immunogenically Silent Tumors. [Internet] [Thesis]. University of Pennsylvania; 2019. [cited 2019 Dec 12]. Available from: https://repository.upenn.edu/edissertations/3529.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Yarmarkovich M. Immunotherapeutic Targeting Of Lineage Restricted Oncoproteins In Immunogenically Silent Tumors. [Thesis]. University of Pennsylvania; 2019. Available from: https://repository.upenn.edu/edissertations/3529

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

29. Lashtur, Nelya. CAR-T cell therapy for liver metastases.

Degree: MS, Physician Assistant Program, 2016, Boston University

 Liver metastases are the most common cause of death in colorectal cancer patients. The standard of care and potential for cure for colorectal liver metastases… (more)

Subjects/Keywords: Immunology; CAR-T cells; Chimeric antigen receptor; Colorectal cancer; Colorectal liver metastases; Immunotherapy; SIRT

…patients post resection 7 2 TCR complex and T cell activation 14 3 Generations 1-4 of CAR-T… …Chimeric Antigen Receptor CAR-T… …immunotherapy using genetically modified chimeric antigen receptor T cells (CAR-T). CAR-T… …delivering a sufficient number of CAR-T while sparing normal organs.5 Current research has been… …attempting to overcome these boundaries to make CAR-T therapy safe and efficient in treating solid… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lashtur, N. (2016). CAR-T cell therapy for liver metastases. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/19196

Chicago Manual of Style (16th Edition):

Lashtur, Nelya. “CAR-T cell therapy for liver metastases.” 2016. Masters Thesis, Boston University. Accessed December 12, 2019. http://hdl.handle.net/2144/19196.

MLA Handbook (7th Edition):

Lashtur, Nelya. “CAR-T cell therapy for liver metastases.” 2016. Web. 12 Dec 2019.

Vancouver:

Lashtur N. CAR-T cell therapy for liver metastases. [Internet] [Masters thesis]. Boston University; 2016. [cited 2019 Dec 12]. Available from: http://hdl.handle.net/2144/19196.

Council of Science Editors:

Lashtur N. CAR-T cell therapy for liver metastases. [Masters Thesis]. Boston University; 2016. Available from: http://hdl.handle.net/2144/19196


Cornell University

30. Vedvyas, Yogindra. SOMATOSTATIN RECEPTOR TYPE 2 (SSTR2) FOR ADOPTIVE T CELL IMAGING, STIMULATION, AND ELIMINATION .

Degree: 2018, Cornell University

 Harnessing the immune system to recognize and destroy tumor cells has been the central goal of anti-cancer immunotherapy. Adoptive cell therapy (ACT) is a treatment… (more)

Subjects/Keywords: Adoptive Cell Therapy (ACT); Chimeric Antigen Receptor (CAR) T cells; Inflammation and Cancer; Intercellular Adhesion Molecule-1 (ICAM-1); Positron emission tomography (PET); Somatostatin Receptor 2 (SSTR2); Biomedical engineering; Immunology; Chemical engineering

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Vedvyas, Y. (2018). SOMATOSTATIN RECEPTOR TYPE 2 (SSTR2) FOR ADOPTIVE T CELL IMAGING, STIMULATION, AND ELIMINATION . (Thesis). Cornell University. Retrieved from http://hdl.handle.net/1813/59687

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Vedvyas, Yogindra. “SOMATOSTATIN RECEPTOR TYPE 2 (SSTR2) FOR ADOPTIVE T CELL IMAGING, STIMULATION, AND ELIMINATION .” 2018. Thesis, Cornell University. Accessed December 12, 2019. http://hdl.handle.net/1813/59687.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Vedvyas, Yogindra. “SOMATOSTATIN RECEPTOR TYPE 2 (SSTR2) FOR ADOPTIVE T CELL IMAGING, STIMULATION, AND ELIMINATION .” 2018. Web. 12 Dec 2019.

Vancouver:

Vedvyas Y. SOMATOSTATIN RECEPTOR TYPE 2 (SSTR2) FOR ADOPTIVE T CELL IMAGING, STIMULATION, AND ELIMINATION . [Internet] [Thesis]. Cornell University; 2018. [cited 2019 Dec 12]. Available from: http://hdl.handle.net/1813/59687.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Vedvyas Y. SOMATOSTATIN RECEPTOR TYPE 2 (SSTR2) FOR ADOPTIVE T CELL IMAGING, STIMULATION, AND ELIMINATION . [Thesis]. Cornell University; 2018. Available from: http://hdl.handle.net/1813/59687

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2]

.